ReviewMetabolic brain disease2022

Alzheimer's disease therapy based on acetylcholinesterase inhibitor/blocker effects on voltage-gated potassium channels.

Xian-Tao LiPubMed ↗Publisher ↗

No numbers read from the abstract.